Immediate Impact

3 from Science/Nature 64 standout
Sub-graph 1 of 20

Citing Papers

Pancreatic cancer
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
2 intermediate papers

Works of David Fenton being referenced

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab
2021
Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
2006

Author Peers

Author Last Decade Papers Cites
David Fenton 663 736 159 247 38 1.2k
P. Harper 270 543 276 210 43 1.1k
Manxia Wu 304 596 155 236 31 1.3k
Paul Rebattu 431 566 69 142 55 913
Joseph Ayoub 404 558 185 483 26 1.1k
W. P. Laird Myers 275 409 168 200 36 1.0k
Leila T. Tchelebi 344 410 137 187 40 956
Konstantinos Kamposioras 190 556 78 203 69 1.0k
Christine M. Bestvina 296 455 83 113 63 901
C Mettlin 454 495 94 82 39 1.2k
R. Morant 484 705 77 238 54 1.3k

All Works

Loading papers...

Rankless by CCL
2026